fibrocell science inc
(FCSC:Consolidated Issue listed on NASDAQ Capital Market)
David M. Pernock
Chairman, Chief Executive Officer and President, Fibrocell Science, Inc.
|Age||Total Calculated Compensation||This person is connected to 83 board members in 4 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. David M. Pernock has been the Chairman and Chief Executive Officer of Fibrocell Science, Inc. since September 2009 and February 1, 2010 respectively and also serves as its President. Mr. Pernock served as the Senior Vice President of U.S., pharmaceuticals/vaccines & Biologics, Specialty Businesses - Philadelphia for GlaxoSmithKline P.L.C. He served in a variety of executive capacities for GlaxoSmithKline (GSK) from 1994 to 2009. Mr. Pernock has been a Director of ...
405 Eagleview BoulevardPhone: 484-713-6000
Exton, Pennsylvania 19341
Board Members Memberships*
Chairman, Chief Executive Officer and President
Arizona State University-Tempe
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Nick Leschly||Chief Executive Officer, President and Director|
bluebird bio, Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Edward O. Lanphier II||Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee|
Sangamo Biosciences Inc.
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2013.|